These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26497773)

  • 1. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
    Moon HH; Kim SH; Ku JL
    Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
    Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK; Zhan Z; Bates SE
    Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
    Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y
    Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
    Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
    Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
    Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
    Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
    Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
    Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 expression, function, and promoter methylation in human multiple myeloma.
    Turner JG; Gump JL; Zhang C; Cook JM; Marchion D; Hazlehurst L; Munster P; Schell MJ; Dalton WS; Sullivan DM
    Blood; 2006 Dec; 108(12):3881-9. PubMed ID: 16917002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
    Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
    Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
    Bram EE; Stark M; Raz S; Assaraf YG
    Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
    Candeil L; Gourdier I; Peyron D; Vezzio N; Copois V; Bibeau F; Orsetti B; Scheffer GL; Ychou M; Khan QA; Pommier Y; Pau B; Martineau P; Del Rio M
    Int J Cancer; 2004 May; 109(6):848-54. PubMed ID: 15027118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
    Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
    Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
    Miyaki Y; Suzuki K; Koizumi K; Kato T; Saito M; Kamiyama H; Maeda T; Shibata K; Shiya N; Konishi F
    Int J Oncol; 2012 Jan; 40(1):217-26. PubMed ID: 21901246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
    Kopp TI; Andersen V; Tjonneland A; Vogel U
    Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.